Asset Management One Co. Ltd. Grows Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Asset Management One Co. Ltd. grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 133.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,229 shares of the medical instruments supplier’s stock after acquiring an additional 1,274 shares during the quarter. Asset Management One Co. Ltd.’s holdings in LeMaitre Vascular were worth $207,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Shaker Investments LLC OH lifted its position in LeMaitre Vascular by 0.8% during the fourth quarter. Shaker Investments LLC OH now owns 13,948 shares of the medical instruments supplier’s stock worth $1,285,000 after buying an additional 112 shares in the last quarter. Glenmede Trust Co. NA lifted its position in LeMaitre Vascular by 1.3% during the third quarter. Glenmede Trust Co. NA now owns 10,512 shares of the medical instruments supplier’s stock worth $976,000 after buying an additional 136 shares in the last quarter. Summit Global Investments lifted its position in LeMaitre Vascular by 2.4% during the third quarter. Summit Global Investments now owns 6,192 shares of the medical instruments supplier’s stock worth $575,000 after buying an additional 146 shares in the last quarter. MML Investors Services LLC lifted its position in LeMaitre Vascular by 2.8% during the third quarter. MML Investors Services LLC now owns 7,107 shares of the medical instruments supplier’s stock worth $660,000 after buying an additional 191 shares in the last quarter. Finally, Albion Financial Group UT lifted its position in LeMaitre Vascular by 5.7% during the fourth quarter. Albion Financial Group UT now owns 3,796 shares of the medical instruments supplier’s stock worth $350,000 after buying an additional 204 shares in the last quarter. Hedge funds and other institutional investors own 84.64% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Oppenheimer reiterated an “outperform” rating and set a $93.00 price objective (up previously from $90.00) on shares of LeMaitre Vascular in a research report on Friday, November 1st. Barrington Research raised their target price on LeMaitre Vascular from $92.00 to $93.00 and gave the stock an “outperform” rating in a research note on Friday, November 1st. Wells Fargo & Company began coverage on LeMaitre Vascular in a research note on Thursday, February 13th. They set an “equal weight” rating and a $95.00 target price for the company. Finally, StockNews.com cut LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Friday, December 13th. Three research analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, LeMaitre Vascular currently has an average rating of “Moderate Buy” and a consensus price target of $94.63.

LeMaitre Vascular Trading Down 2.2 %

Shares of NASDAQ LMAT opened at $100.92 on Friday. LeMaitre Vascular, Inc. has a twelve month low of $59.87 and a twelve month high of $109.58. The stock has a fifty day simple moving average of $96.05 and a 200-day simple moving average of $93.97. The stock has a market capitalization of $2.27 billion, a PE ratio of 55.15, a PEG ratio of 2.21 and a beta of 0.96.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.